The global superficial punctate keratitis treatment industry is slated to reach a valuation of USD 5.3 billion in 2023. According to Future Market Insights, the market is expected to grow at a 6.33% CAGR until 2033, valued at USD 9.6 billion.
The increase in the prevalence of infectious diseases is driving the superficial punctate keratitis treatment industry, where the disease becomes more extensive as soon as the temperature rises. It is also identified that such a type of disease is common in tropical regions, therefore a rise in the global temperature influences the incidence of keratitis, thereby expediting the market.
The global demand for keratitis treatment is being determined by the rise in medical spending. There also have been a few advancements that help in limiting sales growth. With considerable investments, the keratitis treatment industry provides the opportunity for detection of the coronary eye disease by embracing a good perception throughout the coming years. But this disease is also spreading due to the provision of poor sanitary conditions in developing nations.
The disease is transmitted as a result of poor sanitary conditions in developing nations. Although, wearing contact lenses while swimming is another aspect ramping up the contamination of the eye, thus this is also contributing to the contribution of the keratitis treatment.
Recently, intervention in surgery may also be an option for patients with refractory superficial punctate keratitis, not responding to medical treatment, and severe fungal infections. The penetration of keratoplasty is considered to be the most common surgical intervention for serious fungal keratitis and cases with perforation or impending perforation. Modern advances have added more options like targeting the drug delivery at the site of infection in the form of intrastromal injections, collagen cross-linking, and rose Bengal-aided photodynamic therapy.
North America is said to have the dominant share due to the rapid usage of modernization and contact lens, but individuals living in developing countries, specifically in remote regions are said to get more affected because of the lack of access to healthcare providers because of low revenues.
Key Takeaways from the Market Study:
- Around 3.7 billion people under the age of 50 have Superficial Keratitis.
- The global superficial punctate keratitis treatment industry grew at a CAGR of 5.56% from 2018 to 2022.
- PCR is highly sensitive, but a large variation has been observed in numerous studies between the rates of SPK detection by PCR when compared to clinical diagnosis.
- The treatment of Superficial Punctuate keratitis usually involves medicine, including eye drops or antiviral medications taken by mouth.
Increased Market Attention: Delve into Detailed Trends and Analysis with Our Report!
Competitive Landscape:
Some of the prominent players in the global market for Nephroblastoma Therapeutics Market treatment are-
- Dompé Farmaceutici
- Allergan
- Bausch Health Companies Inc.
- CONTACARE
- OHTO Pharmaceutical Co., Ltd.
- Pfizer, Inc.
- Neuroptika
- Santen Pharmaceutical Co., Ltd.
- Johnson & Johnson
- Grand Pharma Co., Ltd.
- Zhejiang CONBA Pharmaceutical Co., Ltd.
Some of the important developments of the key players in the market are:
- In November 2020, Pfizer Inc. completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.
- In September 2020, Bausch Health Companies Inc. agreed to acquire an option to purchase all ophthalmology assets of Allegro Ophthalmics.
- In August 2016, Allergen plc agreed to acquire ForSight VISIONS, a privately held, clinical-stage biotechnology company focused on eye care, for a USD 95 million upfront payment.
Key Segments Profiled in the Superficial Punctuate Keratitis Market Treatment Report:
By Drug Class:
- Amphotericin B
- Griseofulvin
- Voriconazole
By Route of Administration:
- Oral
- Topical
By Distribution Channel:
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube